CWP
AMED

CFM Wealth Partners’s Amedisys AMED Stock Holding History

CFM Wealth Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-903
Closed -$221K – 184
2021
Q2 		$221K Buy
903
+61
+7% +$16K 0.06% 162
2021
Q1 		$223K Sell
842
-67
-7% -$18.9K 0.07% 154
2020
Q4 		$267K Sell
909
-18
-2% -$4.62K 0.09% 126
2020
Q3 		$219K Hold
927
– – 0.08% 138
2020
Q2 		$184K Sell
927
-64
-6% -$11.9K 0.07% 157
2020
Q1 		$182K Hold
991
– – 0.08% 133
2019
Q4 		$180K Buy
+991
New +$147K 0.07% 154

Other funds holding AMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

CFM Wealth Partners's AMED Position: Q3 2021 in Review

CFM Wealth Partners sold out of Amedisys (AMED) in Q3 2021, closing a stake of 903 shares — an estimated $221K sold.

CFM Wealth Partners first reported a position in AMED in Q4 2019 and held it in 7 quarters. The position peaked at $267K in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • CFM Wealth Partners reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
  • CFM Wealth Partners sold 903 Amedisys shares in Q3 2021, an estimated $221K.
  • CFM Wealth Partners first reported a position in Amedisys in Q4 2019 and held it in 7 quarters.
  • CFM Wealth Partners's Amedisys position peaked at $267K in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on CFM Wealth Partners's 13F filing for Q3 2021, filed 25 Oct 2021.